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Telemedicine Screening for Eye Disease
Kurt Kroenke, MD
Telemedicine is increasinglyused fordiseasemonitoringandman-
agement of chronic medical and mental disorders, but also has
screening and diagnostic applications such as teleradiology and
teledermatology. Indeed, “therapy at a distance” will complement
office-based care in the 21st century. Another screening applica-
tion is teleophthalmology, in which digital photography with tele-
medicine links has proven cost-effective for retinal disorders, in-
cluding diabetic retinopathy and retinopathy of prematurity.1,2
Ina recent study in JAMAOphthalmology, Chasanetal3 comple-
mentedpriorcost-effectivenessanalysesof teleretinal screeningpro-
gramsbyexaminingboth theaccuracyofdiabetic teleretinal screen-
ing as well as the subsequent eye care use and resources required
in such a program. Regarding accuracy, screening tests that have
good sensitivity and specificity are likely to bemore cost-effective.
Regarding resource use, implementation of screening generates
more referrals, testing, and procedures. The cost-effectiveness of
any screening program is therefore contingent on reasonable test
accuracy coupledwith a sufficient supply of resources tomeet the
increased demand.
Chasan et al3 conducted the study in community-based clinics
ofasingleVeteransAffairs (VA)medical center.Of 1935patientswho
underwent diabetic retinal screening, 465 (24%) had an abnormal
finding on the retinal photograph and were referred to the VA eye
clinic, of whom 326 were seen by an eye specialist and had a con-
firmatorydiagnosis.Themostcommonreasonsfor referralwerenon-
macular diabetic retinopathy (43.2%), nerve-related disease
(30.8%), lensormediaopacity (19.1%), age-relatedmacular degen-
eration (12.9%), and diabetic macular edema (5.6%). The percent-
ageof agreementbetween retinal screeningand theophthalmicex-
amination for all diagnoseswas 90.4%,with a sensitivity of 73.6%.
Sensitivity may have been somewhat inflated for 2 reasons. First,
onlypatientswithabnormal retinalphotographswere referred, thus
greatly increasing the number of cases with disease and minimiz-
ing thenumberof caseswithoutdisease. This verificationbias (also
known as “workup bias” or “referral bias”) is a type of measure-
mentbias inwhich the resultsof adiagnostic test affectwhether the
gold standard procedure is used to verify the test result. Second, it
is not clear that the clinician performing the ophthalmic examina-
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IMPORTANCE Telemedicine is a useful clinical method to
extend health care to patients with limited access. Minimal
information exists on the subsequent effect of telemedicine
activities on eye care resources.
OBJECTIVE To evaluate the effect of a community-based
diabetic teleretinal screening program on eye care use and
resources.
DESIGN, SETTING, AND PARTICIPANTS The current studywas a
retrospective medical record review of patients who
underwent diabetic teleretinal screening in the
community-based clinics of the Atlanta Veterans Affairs
Medical Center fromOctober 1, 2008, throughMarch 31,
2009, and whowere referred for an ophthalmic examination
in the eye clinic.
EXPOSURES Clinical medical records were reviewed for a
2-year period after patients were referred from teleretinal
screening. The following information was collected for
analysis: patient demographics, referral and confirmatory
diagnoses, ophthalmology clinic visits, diagnostic procedures,
surgical procedures, medications, and spectacle
prescriptions.
MAIN OUTCOMES ANDMEASURES The accuracy between
referring and final diagnoses and the eye care resources that
were used in the care of referred patients.
RESULTS Themost common referral diagnoses were
nonmacular diabetic retinopathy (43.2%), nerve-related
disease (30.8%), lens or media opacity (19.1%), age-related
macular degeneration (12.9%), and diabetic macular edema
(5.6%). The percentage of agreement among these 5 visually
significant diagnoses was 90.4%, with a total sensitivity of
73.6%. Diabetic macular edema required the greatest number
of ophthalmology clinic visits, diagnostic tests, and surgical
procedures. Using Medicare cost data estimates, the mean
cost incurred during a 2-year period per patient seen in the
eye clinic was approximately $1000.
CONCLUSIONS AND RELEVANCEAlthough a teleretinal
screening program can be accurate and sensitive for multiple
visually significant diagnoses, measurable resource burdens
should be anticipated to adequately prepare for the
associated increase in clinical care.
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tionwasmasked to the retinal photograph,which couldbias the cli-
nician toward greater agreement and sensitivity.
Of the465patients referred,260patients (56%)madeandkept
anappointmentat theVAeyeclinic (another66 receivedophthalmic
careoutsidetheVA).UsingMedicarecostdataestimates,themeancost
incurredduringa2-yearperiodperpatientseenintheeyeclinicwasap-
proximately $1000. Costs may have been underestimated because
medicationsandspectacleswerenot includedincostestimates.How-
ever, this isnotasubstantial limitationbecause it isa reflectionofwho
isactually responsible forcertainhealthcarecosts.Someeyemedica-
tionsareconsideredover-the-counterand, likespectacles,maynotbe
coveredbyinsurance.Accordingly,thepatientbearstheadditionalcosts.
Also,screeningcosts(cameras,computers,personneldoingtheimaging
and reading)werenot included in the cost analysis.
Theyieldofscreeningmayhavebeenoverestimatedbecauseonly
43.6%had a visually significant condition detected for the first time.
However, sometimes “the second time is the charm,” notonly for eye
disorders but for other conditions aswell, such as risk factors (hyper-
tension, hyperlipidemia) or behaviors warranting lifestyle changes
(weight loss, smokingcessation, exercise). Patientsmayneed tohear
somethingmore than once before taking a screening result or health
care recommendation seriously and to move through the stages of
changefromprecontemplationtoaction.Ofthepatientsreferred,there
was a 30%nonadherence ratewithmaking and keeping an appoint-
ment in either theVAor anon-VAeyeclinic.Not surprisingly, patients
withhistoricalhighno-showrates formedicalappointmentswere less
likely to keep an appointment. Because neither age nor driving dis-
tancewas associatedwith no-show rates, identifying other potential
barriers (patient preferences for treatment, inadequate education
about risks, less severe symptoms) is important.
Another recent study in JAMAOphthalmologyprovidedpromis-
ingresultsfortelemedicinediagnosisofcytomegalovirusretinitis,adis-
easecommoninresource-poorcountrieswithahighburdenofhuman
immunodeficiencyvirusand limitedaccess tohighlyactiveantiretro-
viral therapy.4Conductingthestudy inThailand,Yenetal4 foundgood
agreementbetweennonexpertandexpertgradersevaluating182fun-
dus photographs: themean sensitivity and specificity values of non-
expertdiagnosisusingexpertconsensusasthereferencestandardwere
93.2%and88.4%,respectively.Meanintraraterreliabilityalsowashigh
(mean κ, 0.83). Training consisted simply of a 2-hourworkshop, and
therewere some raterswith lower accuracy. The authors argued for
more intensive training andperiodic evaluations if nonexperts are to
beusedinclinicalpractice.A2-hourtrainingsessionofnonexpertgrad-
ersproducedsimilaraccuracyfortelemedicaldiagnosisof retinopathy
ofprematurity.5 Incontrast, a telemedicineprogramfordiabetic reti-
nopathyintheUnitedStateshadamoreintense3-daytrainingprogram
afterwhich imagers servedaprobationaryperiodwith senior imager
supervisionandongoingquality improvementandassurance.6Theop-
timal amountof training likelydependsoncurrentorprevioushealth
careexperienceofthetrainees,whetherscreening is focusedon1type
ormultiple typesofeyedisease,andthedegreeofposttrainingsuper-
vision and attention to quality improvement.
A review of 21 articles on the economic evidence for diabetic
retinopathy screening concluded that systematic screening is cost-
effective and that telemedicine retinal screening has the potential
to deliver cost-effective, accessible screening to rural and hard-to-
reach populations.1 However, the authors found that variation in
adherence rates, frequency of screening (annual vs 2- to 3-year
intervals), age at onset of diabetes, glycemic control, and screening
sensitivities influence cost-effectiveness. The cost per quality-
adjusted life-year (QALY) of teleretinal screening for both diabetic
retinopathy and retinopathy of prematurity falls well below the
standard benchmark of $50 000 per QALY.1,2
Thereareseveral implicationsofthisemergingevidencesupport-
ing telemedicine for eyedisorders. First, telemedicine ingeneral is of-
tenpromotedasameansof increasingaccesstocarefor individuals liv-
ing in rural, remote,or resource-poor regions.However, italsomaybe
cost-effectiveinurbanareasbyidentifyingtheindividualswhomayben-
efitmost fromspecialty referral aswell asby reducing timeand travel
costsbyscreeningatcommunityclinicscloser towhere individuals re-
side.Second,telemedicinescreeningmaybemorefeasible,at least for
now, in larger integratedhealthcaresystems like theVA,healthmain-
tenanceorganizations,oraccountablecareorganizations.Arecentstudy
from theVA found that telemedicine screening for diabetic retinopa-
thydidnotbecomecost-effectiveuntilthepatientpoolexceeded3500.7
However,iftheAffordableCareActfulfillsitspromisebyprovidinghealth
coverage for a greater proportionof theUSpopulation, telemedicine
coveragemayalsoexpand.Third,otherfactorsmayidentifysubgroups
inwhich telemedicine screening ismoreor less cost-effective. For ex-
ample, thesameVAstudyfoundthatteleretinalscreeningwasactually
cost-saving inpatientsyoungerthan50years,cost-effectivefor those
aged50to80years,andnolongercost-effectiveafterapatientexceeds
theageof80years.7 Fourth, as telemedicineextends tomanycondi-
tions, lessonslearnedfromonediseasemaygeneralizetoothers.Asthe
pressuresincreaseforhealthcaretobecomemorepatient-centeredand
cost-effective,telemedicineisonestrategyforfosteringbothprinciples.
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